What we've learned about gilteritinib

What we've learned about gilteritinib

obr

1 year
61 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Eunice Wang, MD, talks about what we've learned about gilteritinib in FLT3-ITD mutated acute myeloid leukemia (AML) patients at the 2018 Annual Meeting.
Up Next Autoplay